BALERNA, Switzerland--(BUSINESS WIRE)-- APR Applied Pharma Research s.a. (“APR”), Labtec GmbH (“Labtec”) and Norgine BV (“Norgine”) announce the signature of an exclusive licensing agreement under ...
Deal covers antifungal Loramyc and antiemetic Setofilm and could earn BioAlliance another €42 million. The Therabel Group is paying BioAlliance Pharma an initial €4.5 million, or about $6 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback